Literature DB >> 2558090

Antibodies to Epstein-Barr viral antigens in familial rheumatoid arthritis.

M McDermott, M Molloy, J Buckley, J Greally.   

Abstract

Serum antibodies to Epstein-Barr virus (EBV) were measured in members of twenty-nine families in which two or more first degree relatives had rheumatoid arthritis (RA). These patients were assessed clinically for activity of disease and their treatment recorded. A higher proportion of seropositive individuals was found among patients and affected kindred than among the non-affected groups. Antibody titres to Viral Capsid Antigen (VCA) tended to be higher in patients and affected kindred. In those individuals in whom antibody to Early Antigen (EA) was present there was a lower titre of antibody to Epstein-Barr Nuclear Antigen (ENBA). The results suggest that an immunoregulatory defect may exist in some patients with RA which allows for enhanced expression of EBV.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2558090     DOI: 10.1007/BF02943612

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  16 in total

1.  Serum antibody in rheumatoid arthritis reactive with a cell-associated antigen. Demonstration by precipitation and immunofluorescence.

Authors:  M A Aslpaugh; E M Tan
Journal:  Arthritis Rheum       Date:  1976 Jul-Aug

2.  Coxsackie B infection and arthritis.

Authors:  N P Hurst; A G Martynoga; G Nuki; J R Sewell; A Mitchell; G R Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-19

3.  Antibodies to Epstein-Barr virus-determined antigens in normal subjects and in patients with seropositive rheumatoid arthritis.

Authors:  M A Catalano; D A Carson; S F Slovin; D D Richman; J H Vaughan
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

4.  Isolation of cytomegalovirus from synovial cells of a patient with rheumatoid arthritis.

Authors:  D Hamerman; I Gresser; C Smith
Journal:  J Rheumatol       Date:  1982 Sep-Oct       Impact factor: 4.666

5.  Elevated levels of antibodies to Epstein-Barr virus antigens in sera and synovial fluids of patients with rheumatoid arthritis.

Authors:  M A Alspaugh; G Henle; E T Lennette; W Henle
Journal:  J Clin Invest       Date:  1981-04       Impact factor: 14.808

6.  Genetic control of rheumatoid factor production in the mouse. Role of genes linked to the immunoglobulin heavy chain locus and to the major histocompatibility complex.

Authors:  J L Van Snick; P G Coulie; M Stevens
Journal:  Arthritis Rheum       Date:  1983-09

7.  The suppression of Epstein-Barr virus infection in vitro occurs after infection but before transformation of the cell.

Authors:  D A Thorley-Lawson
Journal:  J Immunol       Date:  1980-02       Impact factor: 5.422

8.  Virus antibody levels and delayed hypersensitivity in rheumatoid arthritis.

Authors:  P E Phillips; J Waxman; Y Hirshaut; M H Kaplan
Journal:  Ann Rheum Dis       Date:  1976-04       Impact factor: 19.103

9.  Chronic arthritis associated with the presence of intrasynovial rubella virus.

Authors:  R Grahame; R Armstrong; N Simmons; J M Wilton; M Dyson; R Laurent; R Millis; C A Mims
Journal:  Ann Rheum Dis       Date:  1983-02       Impact factor: 19.103

10.  Suppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytes.

Authors:  D A Thorley-Lawson; L Chess; J L Strominger
Journal:  J Exp Med       Date:  1977-08-01       Impact factor: 14.307

View more
  4 in total

1.  Isotypes of Epstein-Barr virus antibodies in rheumatoid arthritis: association with rheumatoid factors and citrulline-dependent antibodies.

Authors:  Marie Wulff Westergaard; Anette Holck Draborg; Lone Troelsen; Søren Jacobsen; Gunnar Houen
Journal:  Biomed Res Int       Date:  2015-04-27       Impact factor: 3.411

2.  Effect of Epstein-Barr Virus DNA on the Incidence and Severity of Arthritis in a Rheumatoid Arthritis Mouse Model.

Authors:  Sukayna Fadlallah; Hadi Hussein; Mary-Ann Jallad; Marwa Shehab; Abdo R Jurjus; Ghassan M Matar; Elias A Rahal
Journal:  Front Immunol       Date:  2021-05-10       Impact factor: 7.561

Review 3.  Epstein-Barr virus in systemic autoimmune diseases.

Authors:  Anette Holck Draborg; Karen Duus; Gunnar Houen
Journal:  Clin Dev Immunol       Date:  2013-08-24

4.  Epstein-Barr viral corneal stromal keratitis occurring during rheumatoid arthritis treatment: a case report.

Authors:  Kazuya Yamashita; Rio Sato; Ryuki Fukumoto; Yoshiko Ofuji; Takashi Nagamoto; Hirohisa Kubono; Mari Kawamura; Kotaro Suzuki
Journal:  BMC Ophthalmol       Date:  2022-01-21       Impact factor: 2.209

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.